GEPRAL Trademark

Trademark Overview

On Tuesday, June 23, 2009, a trademark application was filed for GEPRAL with the United States Patent and Trademark Office. The USPTO has given the GEPRAL trademark a serial number of 79072054. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Sunday, June 23, 2019. This trademark is owned by GP PHARM, S.A.. The GEPRAL trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human purposes for use in urology; pharmaceutical preparations for human purposes for the prevention and treatment of disorders of the nervous system; Pharmaceutical preparations for human purposes for the treatment of inflammatory disorders; Pharmaceutical preparations for human purposes for use in oncology and in tissue and organ transplantation; pharmaceutical preparations for human purposes for the treatment of viral, cardiovascular and psychiatric related diseases and disorders; pharmaceutical preparations for human purposes for the prevention and treatment of autoimmune diseases or disorders; peptides for use in urology, oncology and for the treatment of viral, inflammatory, nervous system, cardiovascular, psychiatric and autoimmune diseases or disorders
gepral

General Information

Serial Number79072054
Word MarkGEPRAL
Filing DateTuesday, June 23, 2009
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateSunday, June 23, 2019
Registration Number3822090
Registration DateTuesday, July 20, 2010
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 4, 2010

Trademark Statements

Goods and ServicesPharmaceutical preparations for human purposes for use in urology; pharmaceutical preparations for human purposes for the prevention and treatment of disorders of the nervous system; Pharmaceutical preparations for human purposes for the treatment of inflammatory disorders; Pharmaceutical preparations for human purposes for use in oncology and in tissue and organ transplantation; pharmaceutical preparations for human purposes for the treatment of viral, cardiovascular and psychiatric related diseases and disorders; pharmaceutical preparations for human purposes for the prevention and treatment of autoimmune diseases or disorders; peptides for use in urology, oncology and for the treatment of viral, inflammatory, nervous system, cardiovascular, psychiatric and autoimmune diseases or disorders
Translation of Words in MarkThe wording "GEPRAL" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, February 24, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGP PHARM, S.A.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressES
Party NameGP PHARM, S.A.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressES
Party NameGP PHARM, S.A.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressES

Trademark Events

Event DateEvent Description
Thursday, January 16, 2020NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Thursday, January 16, 2020DEATH OF INTERNATIONAL REGISTRATION
Friday, December 15, 2017TOTAL INVALIDATION PROCESSED BY THE IB
Wednesday, November 1, 2017TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Wednesday, November 1, 2017INVALIDATION PROCESSED
Tuesday, October 24, 2017TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, February 24, 2017CANCELLED SECTION 71
Friday, August 14, 2015NEW REPRESENTATIVE AT IB RECEIVED
Monday, July 20, 2015COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Thursday, May 22, 2014TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sunday, April 21, 2013FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, October 25, 2010FINAL DISPOSITION NOTICE SENT TO IB
Monday, October 25, 2010FINAL DISPOSITION PROCESSED
Thursday, October 21, 2010FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, July 20, 2010REGISTERED-PRINCIPAL REGISTER
Tuesday, May 4, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 4, 2010PUBLISHED FOR OPPOSITION
Monday, March 29, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, March 26, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, March 26, 2010EXAMINER'S AMENDMENT ENTERED
Friday, March 26, 2010NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, March 26, 2010EXAMINERS AMENDMENT E-MAILED
Friday, March 26, 2010EXAMINERS AMENDMENT -WRITTEN
Thursday, March 25, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, March 26, 2010TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, March 26, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 25, 2010TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, October 24, 2009REFUSAL PROCESSED BY IB
Tuesday, September 29, 2009DATA MODIFICATION COMPLETED
Tuesday, September 29, 2009APPLICATION FILING RECEIPT MAILED
Monday, September 28, 2009NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, September 28, 2009REFUSAL PROCESSED BY MPU
Saturday, September 26, 2009NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, September 25, 2009ASSIGNED TO LIE
Friday, September 25, 2009NON-FINAL ACTION WRITTEN
Friday, September 25, 2009ASSIGNED TO EXAMINER
Friday, September 25, 2009NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, September 24, 2009SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

gepral pharmaceutical purposes human preparations disorders treatment diseases autoimmune cardiovascular psychiatric